| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.19 |
9e-05 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |